Today's

top partner

for CFD

Bitcoin Magazine

Quantum BioPharma Boosts Digital Asset Holdings to $5 Million with New Bitcoin Purchase 
In an expansion of its digital asset portfolio, Quantum BioPharma Ltd. has announced the purchase of an additional $500,000 in Bitcoin and other cryptocurrencies, bringing its total holdings to USD $5,000,000. The Canadian biopharmaceutical company made the move after securing approval from its Board of Directors. “Quantum BioPharma Ltd. is pleased to announce that after
This post Quantum BioPharma Boosts Digital Asset Holdings to $5 Million with New Bitcoin Purchase  first appeared on Bitcoin Magazine and is written by Jenna Montgomery.

Bitcoin Magazine

Quantum BioPharma Boosts Digital Asset Holdings to $5 Million with New Bitcoin Purchase 

In an expansion of its digital asset portfolio, Quantum BioPharma Ltd. has announced the purchase of an additional $500,000 in Bitcoin and other cryptocurrencies, bringing its total holdings to USD $5,000,000. The Canadian biopharmaceutical company made the move after securing approval from its Board of Directors.

“Quantum BioPharma Ltd. is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased additional Bitcoin and other cryptocurrencies as part of its strategic efforts. This brings the total amount of BTC and other cryptocurrencies purchased to USD $5,000,000. As previously announced the company will continue to allow for future financing and other transactions to be carried out in cryptocurrency.” 

The investment marks another step in the company’s growth, reinforcing its broader strategy to include Bitcoin into its long-term financial planning and operations. 

“This move reflects the company’s belief in the potential of Bitcoin and other currencies to provide a return on investment for shareholders and to provide some hedge against the dollar. The company is now set up to receive financing in cryptocurrencies as well as executing other types of transactions in cryptocurrencies.”

Quantum BioPharma has taken the steps to ensure that its holdings are managed securely and in compliance with legal and financial regulations, working with a custodian to uphold transparency, and investor trust. 

“The company is holding all its cryptocurrency with a fully compliant custodian. The company emphasizes that all transactions are and will be fully compliant with all relevant financial and audit regulations, ensuring a secure and legal process.”

Quantum BioPharma is known for its work in the biotech space, particularly through its subsidiary Lucid Psycheceuticals Inc., which focuses on neurological treatments like Lucid-MS. With this latest Bitcoin investment, the company joins a growing list of firms hedging traditional finance strategies with BTC. 

While it remains unclear how much of the $5 million is allocated specifically to Bitcoin, the firm’s latest move signals increasing institutional interest in Bitcoin as a long term, viable asset. 

This post Quantum BioPharma Boosts Digital Asset Holdings to $5 Million with New Bitcoin Purchase  first appeared on Bitcoin Magazine and is written by Jenna Montgomery.

Read the full story: Read More“>

Blog powered by G6

Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.

For any inquiries, please contact [email protected]

G6 is free to use portal to find ways to improve your life. We choose carefully posts and partner with the best in field writers to bring you the best content. Since 2006, we are there for you on your way to success.

Find on Facebook Follow on Instagram Connect on LinkedIn

Don't miss out on latest news

Join newsletter

Enable notifications

You got a story to share? Questions?

Just connect our team and let's see

©2006-2023 - All rights reserved - GSIX.ORG

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you can afford to take the high risk of losing your money

All Content on this site is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the Site constitutes professional and/or financial advice, nor does any information on the Site constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. You alone assume the sole responsibility of evaluating the merits and risks associated with the use of any information or other Content on the Site before making any decisions based on such information or other Content. In exchange for using the Site, you agree not to hold G6, Lecira, its affiliates or any third party service provider liable for any possible claim for damages arising from any decision you make based on information or other Content made available to you through the Site.